-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DzFdNHz2ckxrhnWeVf6fUYyjB5xaa/aOTnElrlM3LmRc6fRs8kMs6wFc7Ymyk8Vl
 vEUT+IsqESidDRjbD3ypBg==

<SEC-DOCUMENT>0000892569-02-001371.txt : 20020621
<SEC-HEADER>0000892569-02-001371.hdr.sgml : 20020621
<ACCEPTANCE-DATETIME>20020621164838
ACCESSION NUMBER:		0000892569-02-001371
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20020619
ITEM INFORMATION:		Other events
ITEM INFORMATION:		Financial statements and exhibits
FILED AS OF DATE:		20020621

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		02684580

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		9492601200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a82537e8vk.htm
<DESCRIPTION>FORM 8-K DATED JUNE 19, 2002
<TEXT>
<HTML>
<HEAD>
<TITLE>American Vanguard Corporation  Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center"><FONT size="4"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></FONT>

<div align="center"><FONT size="2"><B>Washington, D.C.
20549</B></FONT></DIV>

<P align="center"><FONT size="4"><B>FORM 8-K</B></FONT>

<P align="center"><FONT size="4"><B>CURRENT REPORT</B></FONT>

<P align="center"><FONT size="2">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934</FONT>

<P align="center"><FONT size="2"><B>DATE OF REPORT &#151; June&nbsp;19, 2002</B></FONT>

<P align="center"><FONT size="4"><B>AMERICAN VANGUARD CORPORATION</B></FONT>

<DIV align="center"><FONT size="2">(Exact name of registrant as specified in its charter)</FONT></DIV>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="36%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="29%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="29%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD align="CENTER" valign="top"><FONT size="2"><B>Delaware</B><BR>
(State of incorporation)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">
<B>0-6354</B><BR>
(Commission File No.)
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2"><B>95-2588080</B><BR>
(IRS Employer No.)</FONT></TD>
</TR>

<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
        <TD align="center" valign="top"><FONT size="2"><B>4695 MacArthur Court, Newport Beach, California</B><BR>
(Address of principal executive offices)</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2"><B>92660</B><BR>
(Zip Code)</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2"><B>(949)&nbsp;260-1200</B><BR>
(Registrant&#146;s telephone number, including area code)</FONT>

<P align="center"><FONT size="2">&nbsp;
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>


<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">Item&nbsp;5. Other Events.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;7. Exhibits.</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003">EXHIBIT INDEX</A></TD></TR>
<TR><TD colspan="9"><A HREF="a82537exv99w5.htm">EXHIBIT 99.5</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>






<!-- link2 "Item&nbsp;5. Other Events." -->
<DIV align="left"><A NAME="000"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;5. Other Events.</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;11, 2002, American Vanguard Corporation issued the press release
attached hereto as Exhibit&nbsp;99.5. The release announced that Amvac Chemical
Corporation, a wholly-owned subsidiary of American Vanguard Corporation, has
acquired the Folex cotton defoliant business conducted in the United States by
Aventis CropScience USA prior to Bayer AG&#146;s acquisition of Aventis CropScience
S.A., all as more particularly described in Exhibit&nbsp;99.5.
</FONT>
<!-- link2 "Item&nbsp;7. Exhibits." -->
<DIV align="left"><A NAME="001"></A></DIV>
<P align="left"><FONT size="2"><B>Item&nbsp;7. Exhibits.</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="5%">&nbsp;</TD>
        <TD width="8%">&nbsp;</TD>
        <TD width="87%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
        <TD><FONT size="2">99.5</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Press release issued June&nbsp;11, 2002.</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">2
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="002"></A></DIV>
<P align="center"><FONT size="2"><B>SIGNATURES</B></FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
</FONT>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR>
        <TD width="50%">&nbsp;</TD>
        <TD width="1%">&nbsp;</TD>
        <TD width="49%">&nbsp;</TD>
</TR>
<TR valign="top">
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD colspan="2"><FONT size="2"><B>AMERICAN VANGUARD CORPORATION</B></FONT></TD>
</TR>

<TR><TD>&nbsp;<BR>&nbsp;</TD></TR>
<TR valign="top">
        <TD><FONT size="2">Date: June&nbsp;19, 2002</FONT></TD>
        <TD><FONT size="2">By:&nbsp;</FONT></TD>
        <TD align="left"><FONT size="2">/s / J. A. Barry</FONT></TD>
</TR>
<TR>
        <TD colspan="2"><FONT size="1">&nbsp;</FONT></TD>
        <TD><HR size="1" noshade color="#000000"></TD>
</TR>
<TR valign="top">
        <TD colspan="2">&nbsp;</TD>
        <TD><FONT size="2">J. A. Barry<BR>
Senior Vice President<br>
Chief Financial Officer</FONT></TD>
</TR>
</TABLE>

<P align="center"><FONT size="2">3
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link1 "EXHIBIT INDEX" -->
<DIV align="left"><A NAME="003"></A></DIV>
<P align="center"><FONT size="2"><B>EXHIBIT INDEX</B></FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="12%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="83%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1"><B>EXHIBIT</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1"><B>NUMBER</B></FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><FONT size="1"><B>DESCRIPTION</B></FONT></TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
        <TD align="center" valign="top"><FONT size="2">99.5</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Press Release issued June&nbsp;11, 2002</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">4
</FONT>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>3
<FILENAME>a82537exv99w5.htm
<DESCRIPTION>EXHIBIT 99.5
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w5</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="right"><FONT size="2"><B>EXHIBIT 99.5</B></FONT>

<P align="center"><FONT size="2"><B>FOR IMMEDIATE RELEASE</B></FONT>

<P align="center"><FONT size="2"><B>AMVAC ACQUIRES FOLEX&#174; COTTON DEFOLIANT BUSINESS</B></FONT>

<P><FONT size="2">NEWPORT BEACH, CA, June&nbsp;11, 2002 &#151; AMVAC Chemical Corporation (AMVAC), a
wholly-owned subsidiary of American Vanguard Corporation (AMEX: AVD), announced
today that it has acquired the Folex cotton defoliant business conducted in the
United States by Aventis CropScience USA prior to Bayer AG&#146;s acquisition of
Aventis CropScience S.A.
</FONT>
<P><FONT size="2">AMVAC has acquired the U.S. EPA end-use product registration for Folex as well
as the Folex trademark and product inventories. In addition, an existing
supply agreement with Bayer Corporation providing for the supply of active
ingredient and access to data in support of the end-use product registration
has been assigned to AMVAC, allowing AMVAC to purchase the active ingredient in
Folex from Bayer. Bayer markets a product under its trademark Def&#174;, which is
similar to Folex, and will continue to sell Def following its acquisition of
Aventis.
</FONT>
<P><FONT size="2">Folex (active ingredient: tribufos), used alone or in combination with other
cotton defoliants, affords excellent defoliation of cotton; a process of
removing the leaves from cotton plants prior to harvest. Defoliation is
important to high crop yields and cotton quality as the leaves of a cotton
plant, if not removed, can stain the white cotton fibers during the harvest
process. AMVAC will begin selling Folex throughout the U.S. cotton-belt during
the third quarter of 2002, and for the first time ever, in a closed-delivery
system.
</FONT>
<P><FONT size="2">Glen Johnson, Senior Vice President of AMVAC, stated, &#147;Folex rounds out our
cotton product portfolio. We sell products to the American cotton farmer that
can be used prior to planting, at planting, during the growing season and now,
with Folex, at harvest. We are looking forward to marketing this important
cotton product later this season and are pleased to see that our business
strategy of growth through the acquisition of niche products continues to be
rewarding for AMVAC and its customer base.&#148;
</FONT>
<P><FONT size="2">AMVAC is a manufacturer and marketer of crop protection and specialty products,
whose corporate strategy focuses on acquiring branded product lines from
multi-national agricultural product companies. Its products include:
Fortress&#174;, Vapam&#174;, K-Pam&#174;, Bidrin&#174;, Dacthal&#174;, PCNB, Dibrom&#174;, Durham&#153;
metaldehyde granules, Amid-Thin&#174;, Citrus Fix&#153;, K-Salt&#153;, Fruitone&#174;, Tre-Hold&#174;
and the azadirachtin products: Ecozin&#153;, Amazin&#153; and Ornazin&#153;. American
Vanguard&#146;s basic strategy is to acquire brand name, niche product lines from
multi-national companies that divest mature products to focus on newly
discovered molecules. In 2001, American Vanguard was named to Forbes&#146;
America&#146;s 2<I>00 Best Small Companies</I>. To learn more about American Vanguard,
please reference the Company&#146;s web site at www.american-vanguard.com.
</FONT>
<P><FONT size="2">The Company, from time to time, may discuss forward-looking information.
Except for the historical information contained in this release, all
forward-looking statements are estimates by the Company&#146;s management and are
subject to various risks and uncertainties that may cause results to differ
from management&#146;s current expectations. Such factors include weather
conditions, changes in regulatory policy and other risks as detailed from
time-to-time in the Company&#146;s SEC reports and filings. All forward-looking
statements, if any, in this release represent the Company&#146;s judgment as of the
date of this release. The Company disclaims, however, any intent or obligation
to update forward-looking statements.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="25%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="30%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="35%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2"><B>CONTACT:</B></FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="center" valign="top"><FONT size="2">
<B>-OR-</B>
</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top"><FONT size="2"><B>AVD&#146;S INVESTOR RELATIONS FIRM</B></FONT></TD>
</TR>
</TABLE>
</CENTER>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="74%">&nbsp;</TD>
        <TD width="3%">&nbsp;</TD>
        <TD width="23%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">American Vanguard Corporation<BR>
Eric G. Wintemute, President &#038; CEO<BR>
(949)&nbsp;260-1200<BR>
AMVAC Chemical Corporation<BR>
Glen D. Johnson, Senior Vice President &#038; Director of Business Development<BR>
David Cassidy, Executive Vice-President<BR>
(949)&nbsp;260-1212</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="right" valign="top"><FONT size="2">
The Equity Group Inc.<BR>
www.theequitygroup.com<BR>
Lauren Barbera<BR>
lbarbera@equityny.com<BR>
(212)&nbsp;836-9610<BR>
Loren G. Mortman<BR>
(212)836-9604</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">####</FONT>


<P align="center"><FONT size="2">5</FONT>


</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
